BAXTER INTERNATIONAL INC
For the period ended Mar 31, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 30, 2026
BAX$25.79+0.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Equity
Condensed Consolidated Statements of Changes in Equity (unaudited)
| For the three months ended March 31, 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International Inc. stockholders' equity | ||||||||||
| Common stock shares | Common stock | Common stock sharesin treasury | Common stock intreasury | Additional contributed capital | Retained earnings | Accumulated other comprehensiveincome (loss) | Total Baxter stockholders' equity | Noncontrolling interests | Total equity | |
| Balance as of January 1, 2026 | 683 | $683 | 169 | $(10,873) | $6,368 | $13,705 | $(3,754) | $6,129 | $(27) | $6,102 |
| Net income (loss) | — | — | — | — | — | (15) | — | (15) | — | (15) |
| Other comprehensive income (loss) | — | — | — | — | — | — | (48) | (48) | — | (48) |
| Stock issued under employee benefit plans and other | — | — | (2) | 136 | (154) | — | — | (18) | — | (18) |
| Dividends declared on common stock | — | — | — | — | — | (5) | — | (5) | — | (5) |
| Balance as of March 31, 2026 | 683 | $683 | 167 | $(10,737) | $6,214 | $13,685 | $(3,802) | $6,043 | $(27) | $6,016 |
| For the three months ended March 31, 2025 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International Inc. stockholders' equity | |||||||||||||||
| Common stock shares · Common stock · Common stock shares in treasury · Common stock in treasury · Additional contributed capital · Retained earnings · Accumulated other comprehensive income (loss) · Total Baxter stockholders' equity · Noncontrolling interests · Total equity | |||||||||||||||
| Balance as of January 1, 2025 | 683 | $683 | 173 | $(11,059) | $6,421 | $14,929 | $(4,010) | $6,964 | $60 | $7,024 | |||||
| Net income (loss) | — | — | — | — | — | 126 | — | 126 | — | 126 | |||||
| Other comprehensive income (loss) | — | — | — | — | — | — | (47) | (47) | — | (47) | |||||
| Reclassification of other comprehensive income (loss) disposed in the Kidney Care separation | — | — | — | — | — | — | 115 | 115 | — | 115 | |||||
| Stock issued under employee benefit plans and other | — | — | (3) | 122 | (112) | — | — | 10 | — | 10 | |||||
| Dividends declared on common stock | — | — | — | — | — | (87) | — | (87) | — | (87) | |||||
| Disposition of noncontrolling interest associated with the Kidney Care separation | — | — | — | — | — | — | — | — | (87) | (87) | |||||
| Balance as of March 31, 2025 | 683 | $683 | 170 | $(10,937) | $6,309 | $14,968 | $(3,942) | $7,081 | $(27) | $7,054 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.